GEMO - Cross-Sectional Study on Female BRCA1/2 Mutation Carriers: Genetic Modifiers of Cancer Risk

Head :
Sinilnikova-Erard Olga, Centre de Recherche en Cancérologie UMR5286 CNRS / U1052 Inserm, Equipe « Génétique du cancer du sein »Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon - Centre Léon Bérard
Stoppa-Lyonnet Dominique, Centre de Recherche INSERM U830, Département de Biologie des tumeurs - Service Génétique

Last update : 07/07/2015 | Version : 1 | ID : 5321

print
Print
xml
XML

Export to XML

Please choose the format :

pdf
PDF
xml
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Which version do you want to export ?

send
Send
General
Identification
Detailed name Cross-Sectional Study on Female BRCA1/2 Mutation Carriers: Genetic Modifiers of Cancer Risk
Sign or acronym GEMO
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation 1245228
General Aspects
Medical area Cancer research
Health determinants Genetic
Keywords alleles, changes, loci, cancer risk
Scientific investigator(s) (Contact)
Name of the director Sinilnikova-Erard
Surname Olga
Address Centre Léon Bérard, Bâtiment Cheney D, 28 rue Laënnec, 69373 Lyon cedex 08
Phone + 33 (0)4 78 78 29 24
Email olga.sinilnikova@lyon.unicancer.fr
Unit Centre de Recherche en Cancérologie UMR5286 CNRS / U1052 Inserm, Equipe « Génétique du cancer du sein »Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon - Centre Léon Bérard
Organization INSERM/CNRS/CLB/UNIVERSITE DE LYON/HOSPICES CIVILS DE
Name of the director Stoppa-Lyonnet
Surname Dominique
Address Service de Génétique, Institut Curie, 26 rue d'Ulm, 75248 Paris Cedex 05
Phone +33 (0)1 44 32 46 97
Email dominique.stoppa-lyonnet@curie.net
Unit Centre de Recherche INSERM U830, Département de Biologie des tumeurs - Service Génétique
Organization INSTITUT CURIE/INSERM/UNIVERSITE PARIS
Collaborations
Funding
Funding status Mixed
Details PHRC, Ile de France Association for International Research, French National League against Cancer, “le cancer du sein, parlons-en!" (Let’s Talk About Breast Cancer!) Association, European Project, Oncological Gene-Environment Study (COGS), Canadian Institutes for Health Research (CIHR).
Governance of the database
Sponsor(s) or organisation(s) responsible UNICANCER
Organisation status Both
Additional contact
Main features
Type of database
Type of database Study databases
Study databases (details) Not-repeated cross-sectional studies (except case control studies)
Database recruitment is carried out by an intermediary A selection of health institutions and services
Database recruitment is carried out as part of an interventional study No
Additional information regarding sample selection. Routinely through oncogenetic consultations (cancer centres and hospitals in the "Groupe UNICANCER" network).
Database objective
Main objective To identify the various loci associated with changes in cancer risk and to identify women from our samples with alleles associated with increased or decreased cancer risk.
Inclusion criteria Female BRCA1/2 mutation carriers who had breast and/or ovarian cancer or are cancer-free.
Population type
Age Adulthood (19 to 24 years)
Adulthood (25 to 44 years)
Adulthood (45 to 64 years)
Elderly (65 to 79 years)
Great age (80 years and more)
Population covered Sick population
Gender Woman
Geography area National
Detail of the geography area France
Data collection
Dates
Date of first collection (YYYY or MM/YYYY) 2002
Size of the database
Size of the database (number of individuals) [1000-10 000[ individuals
Details of the number of individuals 3661(BRCA1 : 2471 ; BRCA2 : 1190).
Data
Database activity Data collection completed
Type of data collected Clinical data
Paraclinical data
Biological data
Clinical data (detail) Direct physical measures
Paraclinical data (detail) Hormone history.
Biological data (detail) Description of BRCA1/BRCA2 mutation.
Presence of a biobank Yes
Contents of biobank DNA
Details of biobank content DNA bank.
Health parameters studied Health event/morbidity
Health event/mortality
Procedures
Data collection method By the genetic oncologist monitoring the patient.
Participant monitoring No
Links to administrative sources No
Promotion and access
Promotion
Link to the document http://ccge.medschl.cam.ac.uk/consortia/cimba/
Access
Terms of data access (charter for data provision, format of data, availability delay) To be defined.
Access to aggregated data Access on specific project only
Access to individual data Access on specific project only

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05

View Edit Create here